Neurogene Inc.
NGNE
$15.22
-$0.29-1.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -80.87M | -75.14M | -53.25M | -47.61M | -40.98M |
| Total Depreciation and Amortization | 3.18M | 3.25M | 3.28M | 3.30M | 3.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.59M | 7.26M | -10.80M | -11.52M | -13.64M |
| Change in Net Operating Assets | -626.00K | -5.96M | -9.31M | -10.25M | -8.21M |
| Cash from Operations | -69.73M | -70.60M | -70.08M | -66.08M | -59.52M |
| Capital Expenditure | -1.52M | -808.00K | -820.00K | -735.00K | -357.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 20.96M | 20.96M | 20.96M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -198.72M | -124.45M | -16.95M | 11.85M | 35.00M |
| Cash from Investing | -200.24M | -125.26M | 3.19M | 32.07M | 55.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -56.00K | -52.00K | -47.00K | -45.00K | -35.00K |
| Issuance of Common Stock | 190.66M | 191.27M | 1.19M | 1.08M | 685.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -7.14M | 87.16M | 85.30M | 85.20M |
| Cash from Financing | 190.60M | 184.07M | 88.30M | 86.34M | 85.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.37M | -11.79M | 21.41M | 52.32M | 81.94M |